CURX
Price:
$0.321
Market Cap:
$9.10M
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Industry
Biotechnology
IPO Date
2025-08-26
Stock Exchange
NASDAQ
Ticker
CURX
According to Curanex Pharmaceuticals Inc Common Stock’s latest financial reports and current stock price. The company's current ROE is -85.41%. This represents a change of 268.08% compared to the average of -23.20% of the last 4 quarters.
The mean historical ROE of Curanex Pharmaceuticals Inc Common Stock over the last ten years is -35.36%. The current -85.41% ROE has changed 141.57% with respect to the historical average. Over the past ten years (40 quarters), CURX's ROE was at its highest in in the December 2023 quarter at 0%. The ROE was at its lowest in in the March 2026 quarter at -38.99%.
Average
-35.36%
Median
-34.80%
Minimum
-71.82%
Maximum
0%
Discovering the peaks and valleys of Curanex Pharmaceuticals Inc Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 124.79%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -71.82%
| Year | ROE | Change |
|---|---|---|
| 2025 | -37.66% | -47.56% |
| 2024 | -71.82% | 124.79% |
| 2023 | -31.95% | -Infinity% |
The current ROE of Curanex Pharmaceuticals Inc Common Stock (CURX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-47.14%
5-year avg
-35.36%
10-year avg
-35.36%
Curanex Pharmaceuticals Inc Common Stock’s ROE is greater than Pulmatrix, Inc. (-102.06%), less than Aspire Biopharma Holdings, Inc. (199.43%), greater than Palisade Bio, Inc. (-36.79%), greater than Longeveron Inc. (-202.41%), greater than Hoth Therapeutics, Inc. (-165.25%), less than Curis, Inc. (805.67%), greater than Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (-1569.05%), greater than Leap Therapeutics, Inc. (-46.86%), less than Daré Bioscience, Inc. (763.44%), greater than BriaCell Therapeutics Corp. (-147.92%),
| Company | ROE | Market cap |
|---|---|---|
| -102.06% | $5.11M | |
| 199.43% | $572.25K | |
| -36.79% | $296.82M | |
| -202.41% | $15.60M | |
| -165.25% | $14.92M | |
| 805.67% | $5.55M | |
| -1569.05% | $10.64M | |
| -46.86% | $31.86M | |
| 763.44% | $19.23M | |
| -147.92% | $5.22M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Curanex Pharmaceuticals Inc Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Curanex Pharmaceuticals Inc Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Curanex Pharmaceuticals Inc Common Stock's ROE?
How is the ROE calculated for Curanex Pharmaceuticals Inc Common Stock (CURX)?
What is the highest ROE for Curanex Pharmaceuticals Inc Common Stock (CURX)?
What is the 3-year average ROE for Curanex Pharmaceuticals Inc Common Stock (CURX)?
What is the 5-year average ROE for Curanex Pharmaceuticals Inc Common Stock (CURX)?
How does the current ROE for Curanex Pharmaceuticals Inc Common Stock (CURX) compare to its historical average?